Identification of a Novel MET Exon 14 Skipping Variant in Lung Adenocarcinoma Sensitive to Crizotinib Treatment

J Thorac Oncol. 2021 Mar;16(3):e17-e19. doi: 10.1016/j.jtho.2020.11.014.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adenocarcinoma of Lung* / drug therapy
  • Adenocarcinoma of Lung* / genetics
  • Crizotinib / therapeutic use
  • Exons / genetics
  • Humans
  • Lung Neoplasms* / drug therapy
  • Lung Neoplasms* / genetics
  • Mutation
  • Protein Kinase Inhibitors / therapeutic use
  • Proto-Oncogene Proteins c-met / genetics

Substances

  • Protein Kinase Inhibitors
  • Crizotinib
  • Proto-Oncogene Proteins c-met